SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049095
Filing Date
2024-04-26
Accepted
2024-04-26 16:06:02
Documents
6
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_bolt_def_14a.htm DEF 14A 828546
2 GRAPHIC img81295513_0.jpg GRAPHIC 16109
3 GRAPHIC img81295513_1.jpg GRAPHIC 1400177
4 GRAPHIC img81295513_2.jpg GRAPHIC 156037
5 GRAPHIC img81295513_3.jpg GRAPHIC 1290223
6 GRAPHIC img81295513_4.jpg GRAPHIC 98655
  Complete submission text file 0000950170-24-049095.txt   4904925
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39988 | Film No.: 24883592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)